Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

62% of millennials would let insurers check social media if it lowered premiums

A majority of millennials—individuals between 18 and 34 years old—are willing to let health insurance companies access their social media, provided their premiums could be lowered, according to a survey from MuleSoft Inc.

6 factors behind PwC's 2019's medical cost trend of 6%

PricewaterhouseCoopers released its report on medical cost trends, which estimates numbers for 2019. The good news? Cost increases have leveled off—rising 6 percent in 2019. But for employers, these increasing expenditures do not lead to improved productivity. Medical costs continue to jump, while growth in labor productivity should remain near 1.1 percent for 2019—below the average annual increase of 2.3 percent in recent decades.

Thumbnail

Physician compensation tied to patient satisfaction, outcomes

The shift by insurance companies from reimbursement to fee-for-service has impacted the way physicians and practices are receiving compensation. In a recent survey conducted by Merritt Hawkins, researchers noted 25 percent of physicians have “compensation tied to quality and patient experience metrics.”

Thumbnail

Trump administration announces tariffs on $50B of Chinese goods—including medical devices

After months of statements, speculation, trade talks, tweets and threats, the U.S. government has officially put tariffs in place on $50 billion worth of products imported from China, including medical imaging equipment. X-ray, CT and MRI equipment are all on the list of products included in this announcement.

Thumbnail

Court rules against insurers seeking $12B in ACA risk corridor payments

In a Thursday, June 14, ruling, a federal appellate court denied claims from health insurers who claimed they were owed billions of dollars from an Affordable Care Act (ACA) program. The court ruled 2-1 against two insurers who wanted the federal government to repay them for covering sicker, more expensive patients than initially expected.

Thumbnail

Physician rating websites struggle to provide high-quality, informational content

Websites where users rate physicians are often lacking in quality standards and transparency, according to a study published June 14 in the Journal of Medical Internet Research.

Thumbnail

All quiet: Stryker says it's not discussing takeover of Boston Scientific

Medical device company Stryker filed a claim with the Securities and Exchange Commission on Wednesday saying it is not in discussions with Boston Scientific on a potential takeover.

Thumbnail

Millions of Americans could be affected by "work-for-Medicaid" ruling

A federal court hearing has been scheduled regarding the Trump administration’s decision to give states the power to enforce work requirements on Medicaid enrollees.

Displaying 3449 - 3456 of 6655

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup